Loss of Apoptosis Regulator through Modulating IAP Expression (ARIA) Protects Blood Vessels from Atherosclerosis*

Background: Macrophages play central roles in the whole process of atherosclerosis. Results: ARIA regulates macrophage foam cell formation at least in part by modulating ACAT-1 expression. Conclusion: ARIA is a novel factor involved in the pathogenesis of atherosclerosis. Significance: Loss of ARIA ameliorated atherosclerosis by reducing macrophage foam cell formation; inhibition of ARIA may represent a new line of therapy against atherosclerosis. Atherosclerosis is the primary cause for cardiovascular disease. Here we identified a novel mechanism underlying atherosclerosis, which is provided by ARIA (apoptosis regulator through modulating IAP expression), the transmembrane protein that we recently identified. ARIA is expressed in macrophages present in human atherosclerotic plaque as well as in mouse peritoneal macrophages. When challenged with acetylated LDL, peritoneal macrophages isolated from ARIA-deficient mice showed substantially reduced foam cell formation, whereas the uptake did not differ from that in wild-type macrophages. Mechanistically, loss of ARIA enhanced PI3K/Akt signaling and consequently reduced the expression of acyl coenzyme A:cholesterol acyltransferase-1 (ACAT-1), an enzyme that esterifies cholesterol and promotes its storage, in macrophages. Inhibition of PI3K abolished the reduction in ACAT-1 expression and foam cell formation in ARIA-deficient macrophages. In contrast, overexpression of ARIA reduced Akt activity and enhanced foam cell formation in RAW264.7 macrophages, which was abrogated by treatment with ACAT inhibitor. Of note, genetic deletion of ARIA significantly reduced the atherosclerosis in ApoE-deficient mice. Oil red-O-positive lipid-rich lesion was reduced, which was accompanied by an increase of collagen fiber and decrease of necrotic core lesion in atherosclerotic plaque in ARIA/ApoE double-deficient mice. Analysis of bone marrow chimeric mice revealed that loss of ARIA in bone marrow cells was sufficient to reduce the atherosclerogenesis in ApoE-deficient mice. Together, we identified a unique role of ARIA in the pathogenesis of atherosclerosis at least partly by modulating macrophage foam cell formation. Our results indicate that ARIA could serve as a novel pharmacotherapeutic target for the treatment of atherosclerotic diseases.

[1]  S. Matoba,et al.  Aging differentially alters the expression of angiogenic genes in a tissue-dependent manner. , 2014, Biochemical and biophysical research communications.

[2]  H. Yamada,et al.  Manipulation of Cardiac Phosphatidylinositol 3-Kinase (PI3K)/Akt Signaling by Apoptosis Regulator through Modulating IAP Expression (ARIA) Regulates Cardiomyocyte Death during Doxorubicin-induced Cardiomyopathy* , 2013, The Journal of Biological Chemistry.

[3]  Y. Oike,et al.  Ecscr regulates insulin sensitivity and predisposition to obesity by modulating endothelial cell functions , 2013, Nature Communications.

[4]  Randall C. Thompson,et al.  Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations , 2013, The Lancet.

[5]  E. Podrez,et al.  Akt3 deficiency in macrophages promotes foam cell formation and atherosclerosis in mice. , 2012, Cell metabolism.

[6]  Jing Ye,et al.  Lipid homeostasis and the formation of macrophage-derived foam cells in atherosclerosis , 2012, Protein & Cell.

[7]  H. Matsubara,et al.  Apoptosis regulator through modulating IAP expression (ARIA) controls the PI3K/Akt pathway in endothelial and endothelial progenitor cells , 2011, Proceedings of the National Academy of Sciences.

[8]  K. Moore,et al.  Macrophages in the Pathogenesis of Atherosclerosis , 2011, Cell.

[9]  Y. Huang,et al.  Evaluation of foam cell formation in cultured macrophages: an improved method with Oil Red O staining and DiI-oxLDL uptake , 2010, Cytotechnology.

[10]  H. Matsubara,et al.  Paracrine Osteogenic Signals via Bone Morphogenetic Protein-2 Accelerate the Atherosclerotic Intimal Calcification In Vivo , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[11]  Koji Ikeda,et al.  Identification of ARIA regulating endothelial apoptosis and angiogenesis by modulating proteasomal degradation of cIAP-1 and cIAP-2 , 2009, Proceedings of the National Academy of Sciences.

[12]  M. Birnbaum,et al.  Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. , 2007, Cell metabolism.

[13]  Hideyuki Kobayashi,et al.  A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels. , 2007, Atherosclerosis.

[14]  Robert V Farese.  The nine lives of ACAT inhibitors. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[15]  Carl J Pepine,et al.  Effect of ACAT inhibition on the progression of coronary atherosclerosis. , 2006, The New England journal of medicine.

[16]  K. Ley,et al.  Macrophage differentiation to foam cells. , 2005, Current pharmaceutical design.

[17]  J. Deanfield,et al.  Systemic Acyl-CoA:Cholesterol Acyltransferase Inhibition Reduces Inflammation and Improves Vascular Function in Hypercholesterolemia , 2005, Circulation.

[18]  Fernando Alfonso,et al.  Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic Lesions , 2004, Circulation.

[19]  Sidney C. Smith,et al.  Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. , 2004, Circulation.

[20]  M. Linton,et al.  Macrophages, inflammation, and atherosclerosis , 2003, International Journal of Obesity.

[21]  Alan Daugherty,et al.  T lymphocytes in atherosclerosis: the yin-yang of Th1 and Th2 influence on lesion formation. , 2002, Circulation research.

[22]  S. Perrey,et al.  Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis. , 2001, Atherosclerosis.

[23]  Robert V Farese,et al.  Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages. , 2001, The Journal of clinical investigation.

[24]  S. Perrey,et al.  Absence of ACAT-1 Attenuates Atherosclerosis but Causes Dry Eye and Cutaneous Xanthomatosis in Mice with Congenital Hyperlipidemia* , 2000, The Journal of Biological Chemistry.

[25]  T. Major,et al.  The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[26]  P. Bachorik,et al.  Novel effects of the acyl-coenzyme A:Cholesterol acyltransferase inhibitor 58-035 on foam cell development in primary human monocyte-derived macrophages. , 1999, Arteriosclerosis, thrombosis, and vascular biology.